You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 16, 2024

CLINICAL TRIALS PROFILE FOR XIAFLEX


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for XIAFLEX

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00261196 ↗ Collagenase in the Treatment of Adhesive Capsulitis (Frozen Shoulder) Withdrawn Biospecifics Technologies Corp. Phase 2 2006-01-01 The purpose of this study is to test collagenase injection therapy to dissolve adhesions causing frozen shoulder.
NCT00261196 ↗ Collagenase in the Treatment of Adhesive Capsulitis (Frozen Shoulder) Withdrawn Stony Brook University Phase 2 2006-01-01 The purpose of this study is to test collagenase injection therapy to dissolve adhesions causing frozen shoulder.
NCT01237964 ↗ Injectable Collagenase For Burns' Associated Contracture Unknown status Sheba Medical Center Phase 2 2011-03-01 A pilot experiment to test the efficiency of the enzyme Collagenase in treating contractures which result's from burn's healing process. So far, treatment of choice in patients with burn's created movement limiting contractures, concentrated around supportive care. Patients were referred to surgical intervention only if necessary. Treatment by injecting an external enzyme is avant-garde and hasn't been done under such conditions. This study might introduce a new kind of treatment, which can be done in ambulatory environment .This type of treatment might significantly improve patients' function and quality of life, with no need for a surgical intervention.
NCT01613313 ↗ A Dose Escalation Study Using Collagenase Clostridium Histolyticum in the Treatment of Lipoma Completed Advance Biofactures Corporation Phase 2 2012-05-01 The purpose of this research is to evaluate the safest and most effective dose of a Food and Drug Administration (FDA) approved drug (XIAFLEX) in the treatment of lipoma (fatty tumors of varying sizes that occur commonly in the adult population). The fat in the lipoma is like normal fat except that it is enclosed in a balloon-like structure which is made of collagen (fibrous tissue). Treatment of the lipoma with an injection of XIAFLEX (a protein that breaks down collagen fibers) may dissolve the collagen/fibrous strands thereby decreasing the size of the lipoma or removing it.
NCT01613313 ↗ A Dose Escalation Study Using Collagenase Clostridium Histolyticum in the Treatment of Lipoma Completed Zachary Gerut Phase 2 2012-05-01 The purpose of this research is to evaluate the safest and most effective dose of a Food and Drug Administration (FDA) approved drug (XIAFLEX) in the treatment of lipoma (fatty tumors of varying sizes that occur commonly in the adult population). The fat in the lipoma is like normal fat except that it is enclosed in a balloon-like structure which is made of collagen (fibrous tissue). Treatment of the lipoma with an injection of XIAFLEX (a protein that breaks down collagen fibers) may dissolve the collagen/fibrous strands thereby decreasing the size of the lipoma or removing it.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for XIAFLEX

Condition Name

Condition Name for XIAFLEX
Intervention Trials
Peyronie Disease 4
Dupuytren Contracture 3
Dupuytren's Disease 2
Erectile Dysfunction 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for XIAFLEX
Intervention Trials
Penile Induration 7
Dupuytren Contracture 5
Contracture 4
Lipoma 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for XIAFLEX

Trials by Country

Trials by Country for XIAFLEX
Location Trials
United States 13
Canada 3
Israel 1
Norway 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for XIAFLEX
Location Trials
Florida 4
New York 4
Minnesota 2
Utah 1
Massachusetts 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for XIAFLEX

Clinical Trial Phase

Clinical Trial Phase for XIAFLEX
Clinical Trial Phase Trials
Phase 4 7
Phase 3 2
Phase 2 5
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for XIAFLEX
Clinical Trial Phase Trials
Recruiting 4
Unknown status 4
Completed 3
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for XIAFLEX

Sponsor Name

Sponsor Name for XIAFLEX
Sponsor Trials
Endo Pharmaceuticals 4
Mayo Clinic 2
Advance Biofactures Corporation 2
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for XIAFLEX
Sponsor Trials
Other 19
Industry 8
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.